Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG)

Autor: Renata Peixoto Barbosa

Revista: AE&M, 2024; v.68, 1–15, e230314.